Header

UZH-Logo

Maintenance Infos

Metabolic effects of inhaled salbutamol determined by exhaled breath analysis


Gaugg, Martin T; Engler, Anna; Nussbaumer-Ochsner, Yvonne; Bregy, Lukas; Stöberl, Anna S; Gaisl, Thomas; Bruderer, Tobias; Zenobi, Renato; Kohler, Malcolm; Martinez-Lozano Sinues, Pablo (2017). Metabolic effects of inhaled salbutamol determined by exhaled breath analysis. Journal of breath research, 11(4):046004.

Abstract

We explore whether real-time breath analysis by high resolution mass spectrometry is suitable to monitor changes at the metabolic level due to inhaling bronchodilator medication. We compared the breath levels of metabolites in a group of patients (n = 50) at baseline and 10 and 30 min after inhalation of 200 μg salbutamol. The same procedure was performed with a group of controls (n = 48) inhaling a placebo spray. A total of 131 mass spectral features were significantly altered as a result of inhaling medication, but not after inhaling placebo. We found that homologous series of chemical classes correlated strongly with each other, strengthening the notion that certain biochemical processes can be monitored. For example, a series of fatty acids was found to be increased after salbutamol intake, suggesting lipolysis stimulation. Peaks corresponding to salbutamol, its main metabolite salbutamol-4-O-sulfate and formoterol were found to be generally increased in patients inhaling the drugs on an as-needed basis, as compared to non-medicated volunteers. Overall, these results suggest such real-time breath analysis is a useful tool for non-invasive therapeutic drug monitoring.

Abstract

We explore whether real-time breath analysis by high resolution mass spectrometry is suitable to monitor changes at the metabolic level due to inhaling bronchodilator medication. We compared the breath levels of metabolites in a group of patients (n = 50) at baseline and 10 and 30 min after inhalation of 200 μg salbutamol. The same procedure was performed with a group of controls (n = 48) inhaling a placebo spray. A total of 131 mass spectral features were significantly altered as a result of inhaling medication, but not after inhaling placebo. We found that homologous series of chemical classes correlated strongly with each other, strengthening the notion that certain biochemical processes can be monitored. For example, a series of fatty acids was found to be increased after salbutamol intake, suggesting lipolysis stimulation. Peaks corresponding to salbutamol, its main metabolite salbutamol-4-O-sulfate and formoterol were found to be generally increased in patients inhaling the drugs on an as-needed basis, as compared to non-medicated volunteers. Overall, these results suggest such real-time breath analysis is a useful tool for non-invasive therapeutic drug monitoring.

Statistics

Citations

Dimensions.ai Metrics
4 citations in Web of Science®
2 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

22 downloads since deposited on 23 Jan 2018
22 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Pneumology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:13 September 2017
Deposited On:23 Jan 2018 13:44
Last Modified:19 Aug 2018 13:15
Publisher:IOP Publishing
ISSN:1752-7155
OA Status:Hybrid
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1088/1752-7163/aa7caa
PubMed ID:28901297
Project Information:
  • : FunderFP7
  • : Grant ID276860
  • : Project TitleCMPTIMSMS - Cancer metabolic profiling through ion mobility and mass spectrometric-based methods

Download

Download PDF  'Metabolic effects of inhaled salbutamol determined by exhaled breath analysis'.
Preview
Content: Published Version
Filetype: PDF
Size: 1MB
View at publisher
Licence: Creative Commons: Attribution 3.0 Unported (CC BY 3.0)